Cart
sales@molnova.com
13β,21-Dihydroxyeurycomanone
CAS No. 138874-44-9
13β,21-Dihydroxyeurycomanone( ——— )
Catalog No. M39065 CAS No. 138874-44-9
Pasakbumin D is a quassinoid and can be used for the research of cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 1408 | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name13β,21-Dihydroxyeurycomanone
-
NoteResearch use only, not for human use.
-
Brief DescriptionPasakbumin D is a quassinoid and can be used for the research of cancer.
-
DescriptionPasakbumin D is a quassinoid and can be used for the research of cancer.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number138874-44-9
-
Formula Weight442.417
-
Molecular FormulaC20H26O11
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tada, H., et al. New antiulcer quassinoids from Eurycoma longifolia. European Journal of Medicinal Chemistry, 26(3), 345–349.
molnova catalog
related products
-
AZD1208
AZD1208 is a novel, orally bioavailable, highly selective PIM kinase inhibitor with single nanomolar potency against all three PIM kinases.
-
JMJD7-IN-1
JMJD7-IN-1 is a potent?JMJD7?inhibitor, with an?IC50?of 6.62 μM. JMJD7-IN-1 shows good inhibitory activity against cells expressing a high level of JMJD7.
-
Moxnidazole
Moxnidazole, a 5-nitroimidazole, is mutagenic in microbial assays and in Drosophila, inducing genetic alterations in mouse somatic cells.
